15
CLINICAL RESEARCH: PART 3

CLINICAL RESEARCH: PART 3. Overview Randomized Controlled Trials Experiments in clinical settings Key considerations Control groups Basics are

Embed Size (px)

Citation preview

Page 1: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

CLINICAL RESEARCH: PART 3

Page 2: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Overview

Randomized Controlled Trials Experiments in clinical settings Key considerations Control groups

Basics are simple, but also an incredibly complex methodology

Page 3: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Randomized Controlled Trial

Simply an experiment designed to influence a clinical outcome Experiment = random assignment across

two or more conditions Clinical outcome = physical or mental

health outcome (notably somewhat ambiguous)

Page 4: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Key Considerations

Aims (Goals) of the research Participants (eligibility, sample size, and

accrual) Intervention(s) and control condition(s) Randomization procedures Measures Timeline

Page 5: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Control Groups

Placebo Substance lacking an active treatment

ingredient Any observed effect (placebo effect) is due

to a self-fulfilling prophecy Inert vs. active placebo

Waitlist Treatment as Usual (or Usual Care) Alternative Intervention

Ethical issues? Scientific issues?

Page 6: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Ethics

Placebo Many treatments are harmful if not toxic in

the short-run, have unknown long-term side effects, are ineffective, and/or expensive

Waitlist Many communities lack resources to avoid

waitlists

Page 7: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Scientific Rigor

Designed to increase internal validity (strengthen causal conclusions)

Goal: Make all conditions identical, except for the specific elements thought to cause change Any observed group differences can be attributed to the active element(s) of the intervention

PCORI’s Methodologic Committee recommends using an Alternative Intervention for comparison, well-defined Usual Care, or “Enhanced” Usual Care Comparative Effectiveness Research

Page 8: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: SSRIs

Waitlist

Inert Placebo

Active Placebo

SSRIRegression

Towardthe Mean

Pill-relatedSelf-fulfilling

Prophecy

Side effect-relatedSelf-fulfilling

Prophecy

SerotonergicSpecificEffects

RegressionToward

the Mean

Pill-relatedSelf-fulfilling

Prophecy

Side effect-relatedSelf-fulfilling

Prophecy

RegressionToward

the Mean

Pill-relatedSelf-fulfilling

Prophecy

RegressionToward

the Mean

Page 9: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: SSRIs

Waitlist

Inert Placebo

Active Placebo

SSRIRegression

Towardthe Mean

Pill-relatedSelf-fulfilling

Prophecy

Side effect-relatedSelf-fulfilling

Prophecy

SerotonergicSpecificEffects

RegressionToward

the Mean

Pill-relatedSelf-fulfilling

Prophecy

Side effect-relatedSelf-fulfilling

Prophecy

RegressionToward

the Mean

Pill-relatedSelf-fulfilling

Prophecy

RegressionToward

the Mean

Made-up Remission Rates

10%

20%

30%

35%

What accounts for the differences between one condition and another?

Which comparison is most scientifically valid?

Which comparison yield the biggest difference?

Page 10: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are
Page 11: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: Medicaid PTSD Treatment

Waitlist

CBT

GroupTherapy

CBT + Group Therapy

RegressionToward

the Mean

Cognitive/BehavioralMethods

GroupProcess

Warmth, Empathy, Genuineness,

Problem-Solving

RegressionToward

the Mean

RegressionToward

the Mean

RegressionToward

the Mean

Warmth, Empathy, Genuineness,

Problem-Solving

Warmth, Empathy, Genuineness,

Problem-Solving

Cognitive/BehavioralMethods

GroupProcess

Page 12: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: Medicaid PTSD Treatment

Waitlist

CBT

GroupTherapy

CBT + Group Therapy

RegressionToward

the Mean

Cognitive/BehavioralMethods

GroupProcess

Warmth, Empathy, Genuineness,

Problem-Solving

RegressionToward

the Mean

RegressionToward

the Mean

RegressionToward

the Mean

Warmth, Empathy, Genuineness,

Problem-Solving

Warmth, Empathy, Genuineness,

Problem-Solving

Cognitive/BehavioralMethods

GroupProcess

10%

40%

35%

60%

Page 13: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: Medicaid PTSD Treatment

Waitlist

CBT Cognitive/BehavioralMethods

Warmth, Empathy, Genuineness,

Problem-Solving

RegressionToward

the Mean

RegressionToward

the Mean10%

40%

Page 14: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: Medicaid PTSD Treatment

Waitlist

CBT

GroupTherapy

Cognitive/BehavioralMethods

GroupProcess

Warmth, Empathy, Genuineness,

Problem-Solving

RegressionToward

the Mean

RegressionToward

the Mean

Warmth, Empathy, Genuineness,

Problem-Solving

40%

35%

Page 15: CLINICAL RESEARCH: PART 3. Overview  Randomized Controlled Trials  Experiments in clinical settings  Key considerations  Control groups  Basics are

Example: Medicaid PTSD Treatment

Waitlist

CBT

GroupTherapy

CBT + Group Therapy

RegressionToward

the Mean

Cognitive/BehavioralMethods

Warmth, Empathy, Genuineness,

Problem-Solving

RegressionToward

the Mean

Warmth, Empathy, Genuineness,

Problem-Solving

Cognitive/BehavioralMethods

GroupProcess

40%

60%